Tc-99m sestamibi uptake by parathyroid carcinoma: False-positive localization of parathyroid adenoma

D. M. Achong, E. Oates

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Tc-99m sestamibi (MIBI) is increasingly used for the preoperative localization of parathyroid adenoma. As experience is gained with this radiopharmaceutical, instances of uptake by non-adenomas will be encountered. A case of focal Tc-99m MIBI uptake by parathyroid carcinoma mimicking parathyroid adenoma is presented.

Original languageEnglish
Pages (from-to)735
Number of pages1
JournalClinical Nuclear Medicine
Volume20
Issue number8
DOIs
StatePublished - 1995

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of 'Tc-99m sestamibi uptake by parathyroid carcinoma: False-positive localization of parathyroid adenoma'. Together they form a unique fingerprint.

Cite this